QLT (Rights to Aczone) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

QLT (Rights to Aczone) General Information

Description

Distribution rights of a drug. The asset gel product is used for the treatment of acne vulgaris in patients 12 years and older.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Business Products and Services
Pharmaceuticals
Acquirer
Primary Office
  • 887 Great Northern Way
  • Suite 250
  • Vancouver, British Columbia V5T 4T5
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

QLT (Rights to Aczone) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore QLT (Rights to Aczone)‘s full profile, request access.

Request a free trial

QLT (Rights to Aczone) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore QLT (Rights to Aczone)‘s full profile, request access.

Request a free trial